FDA Approves New COVID Vaccine
Digest more
Nearly 4,500 cases were pulled from shelves in 23 states after it was found that the affected cans had been mislabeled.
By Stephanie Brown HealthDay ReporterMONDAY, May 19, 2025 (HealthDay News) -- Last week, the U.S. Food and Drug Administration announced a move to improve transparency and strengthen the safety of chemicals used in the nation's food supply.
The US Food and Drug Administration has cleared the first-ever blood test for diagnosing Alzheimer's disease, offering a less invasive and simpler alternative for the millions of seniors facing cognitive decline.
The agency is planning a new review process that could result in ingredient bans or additional labeling requirements, according to HHS Secretary Robert F. Kennedy Jr.
The U.S. Food and Drug Administration (FDA) has cleared marketing for a new blood test to diagnose Alzheimer's disease in people who are already exhibiting symptoms.This new test is the first blood test ever approved for diagnostics of the disease,
Explore more
The FDA has granted 510(k) marketing clearance to the first in vitro blood-based biomarker diagnostic device for Alzheimer’s disease. Fujirebio’s Lumipulse G pTau217/ -Amyloid 1-42 Plasma Ratio was developed for the early detection of amyloid plaques associated with AD in adults aged 55 years and older who show signs of the condition,
Japan-based Fujirebio's test, which helps doctors diagnose Alzheimer's disease, is intended for patients with signs of cognitive decline.
3h
ValleyCentral.com on MSNFDA approves first-ever Alzheimer’s blood testA few days ago, the U.S. Food and Drug Administration (FDA) cleared the first blood test to help detect early stages of Alzheimer’s Disease. The blood test
US Food and Drug Administration Commissioner Marty Makary named agency veterans to lead tobacco regulation and inspections, two high-profile areas, according to documents seen by Bloomberg.